Web Date: December 7, 2016
CRISPR creators duke it out in U.S. patent court
In the biggest science showdown of the year, attorneys defending rival CRISPR/Cas9 gene editing patents faced off at the U.S. Patent & Trademark Office (USPTO) in Alexandria, Va., yesterday. The public hearing attracted a large turnout that spilled into two overflow rooms, with one attendee describing it as a “spectator sport” for patent lawyers and investors.
CRISPR technology is regularly hailed as the biggest biotech breakthrough since the DNA-amplifying PCR method was invented. The tool . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society